Cathy Pareto & Associates, Inc Abb Vie Inc. Transaction History
Cathy Pareto & Associates, Inc
- $109 Billion
- Q4 2024
A detailed history of Cathy Pareto & Associates, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cathy Pareto & Associates, Inc holds 1,799 shares of ABBV stock, worth $304,390. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,799Holding current value
$304,390% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,865Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$8.85 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.55 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $299B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...